This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Vanguard Health Systems Reports Fourth Quarter And Year End Fiscal 2012 Results

Vanguard Health Systems, Inc. (NYSE: VHS) today announced financial and operating results for its fourth fiscal quarter and year ended June 30, 2012 and issued its outlook for fiscal 2013.

Fourth Quarter Fiscal 2012 Key Metrics (all percentage changes compare Q4 FY2012 to Q4 FY2011):

Consolidated:
  • Net income attributable to Vanguard Health Systems, Inc. stockholders was $19.3 million, or $0.24 per diluted share, compared to a net loss of $11.0 million, or $(0.23) per diluted share, during the prior year period
  • Adjusted EBITDA increased 9.6 percent to $140.8 million

Same Store:
  • Adjusted discharges increased 0.8 percent
  • Patient revenue per adjusted discharge increased 2.4 percent
  • Discharges declined 1.5 percent

Fiscal 2012 Key Metrics (all percentage changes compare fiscal year 2012 to fiscal year 2011):

Consolidated:
  • Total revenues increased $1,367.3 million or 29.8 percent
  • Net income attributable to Vanguard Health Systems, Inc. stockholders was $57.3 million, or $0.71 per diluted share, compared to a loss of $12.0 million, or $(0.26) per diluted share, during the prior year
  • Adjusted EBITDA increased 36.7 percent to $575.7 million, including the previously disclosed $34.6 million positive impact of updates to Medicare reimbursement estimates related to the rural floor provision of the Balanced Budget Act of 1997 and Supplemental Security Income ratios that occurred during the third quarter of fiscal 2012

Same Store:
  • Net patient service revenues increased 5.9 percent and health plan premium revenues declined 16.1 percent
  • Adjusted discharges increased 1.4 percent
  • Patient revenue per adjusted discharge increased 4.3 percent
  • Discharges declined 2.1 percent

A reconciliation of Adjusted EBITDA, a non-GAAP financial measure, to net income (loss) attributable to Vanguard Health Systems, Inc. stockholders for the quarters and years ended June 30, 2011 and 2012 is included in this release.

1 of 12

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,618.77 +22.42 0.13%
S&P 500 2,067.13 +9.49 0.46%
NASDAQ 4,995.3970 +36.9290 0.74%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs